Hyperendemic dengue transmission and identification of a locally evolved DENV-3 lineage, Papua New Guinea 2007-2010 by Luang-Suarkia, Dagwin et al.
RESEARCH ARTICLE
Hyperendemic dengue transmission and
identification of a locally evolved DENV-3
lineage, Papua New Guinea 2007-2010
Dagwin Luang-Suarkia1¤, Oriol Mitja2, Timo Ernst1, Shannon Bennett3, Alfred Tay1,
Russell Hays4, David W. Smith5, Allison Imrie1*
1 School of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Western Australia,
Nedlands, Western Australia, Australia, 2 Lihir Medical Centre, Lihir Island, Papua New Guinea,
3 Department of Microbiology, California Academy of Sciences, San Francisco, California, United States of
America, 4 James Cook University, Cairns, Queensland, Australia, 5 Pathwest Laboratory Medicine WA,
Nedlands, Western Australia, Australia





Dengue is endemic in the Western Pacific and Oceania and the region reports more than
200,000 cases annually. Outbreaks of dengue and severe dengue occur regularly and
movement of virus throughout the region has been reported. Disease surveillance systems,
however, in many areas are not fully established and dengue incidence is underreported.
Dengue epidemiology is likely least understood in Papua New Guinea (PNG), where the
prototype DENV-2 strain New Guinea C was first isolated by Sabin in 1944 but where routine
surveillance is not undertaken and little incidence and prevalence data is available.
Methodology/Principal findings
Serum samples from individuals with recent acute febrile illness or with non-febrile condi-
tions collected between 2007–2010 were tested for anti-DENV neutralizing antibody.
Responses were predominantly multitypic and seroprevalence increased with age, a pattern
indicative of endemic dengue. DENV-1, DENV-2 and DENV-3 genomes were detected by
RT-PCR within a nine-month period and in several instances, two serotypes were identified
in individuals sampled within a period of 10 days. Phylogenetic analysis of whole genome
sequences identified a DENV-3 Genotype 1 lineage which had evolved on the northern
coast of PNG which was likely exported to the western Pacific five years later, in addition to
a DENV-2 Cosmopolitan Genotype lineage which had previously circulated in the region.
Conclusions/Significance
We show that dengue is hyperendemic in PNG and identify an endemic, locally evolved line-
age of DENV-3 that was associated with an outbreak of severe dengue in Pacific countries
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Author summary
Dengue virus (DENV) was first identified in Papua New Guinea (PNG) in 1944. Dengue
is currently assumed to be an endemic disease in PNG although there is little incidence or
prevalence data, and the evidence consensus for dengue presence is low. Routine surveil-
lance is not undertaken and dengue is not a notifiable disease. Severe dengue is rarely
identified by local clinicians and the reasons for this are unclear but may be related to
poor recognition of dengue and a low index of suspicion, despite high incidence and prev-
alence rates in neighbouring countries. For example, Indonesia shares borders with PNG
and regularly reports outbreaks of severe dengue and transmission of multiple DENV
serotypes. DENV infection is identified in travellers from PNG however there are no data
on locally circulating strains and how they may compare to viruses associated with severe
dengue epidemics in other countries in the Asia Pacific region. We identified evidence for
previous infection with all four DENV serotypes among people living on the northern
coast of PNG, in Madang, and on Lihir Island in the Bismarck Archipelago off the north-
eastern coast. We also detected DENV-1, DENV-2, and DENV-3 virus in febrile patients,
and we describe the first whole genome sequences of endemically circulating DENV since
the prototype 1944 DENV-2New Guinea C strain was characterized. Of note, severe dengue
was not diagnosed in any patient infected with these viruses in PNG although introduc-
tion of the PNG DENV-3 strain into the Solomon Islands five years later resulted in a
large outbreak of severe dengue with hospitalizations and deaths in that country. Dengue
epidemiology and burden of disease should be investigated in PNG.
Introduction
The dengue viruses (DENV) are the most important arboviral pathogens of humans causing
an estimated 390 million infections annually, of which approximately one quarter are symp-
tomatic [1]. Infection with DENV causes a spectrum of clinical outcomes ranging from self-
limiting febrile illness (dengue fever, DF) to potentially fatal severe dengue, characterized by
plasma leakage, thrombocytopenia, and hypovolemic shock. Dengue is endemic in more than
100 tropical and subtropical countries, where the principal mosquito vectors Aedes aegypti and
Aedes albopictus are found [2, 3].
DENV is a single-stranded positive-sense RNA virus of the Flaviviridae family. Like other
RNA viruses, DENV displays considerable genetic diversity and is grouped into four antigeni-
cally distinct serotypes (DENV-1-DENV-4) which may be distinguished on the basis of serum
neutralization tests. The four serotypes are more precisely classified, using phylogenetic
approaches, into distinct genotypes which have been defined as clusters with nucleotide
sequence divergence of not more than 6% [4]; lineages within the genotypes may represent
strains with similar geographic origins [5]. Certain genotypes have been associated with more
[6,7] or less [8] virulent disease, and there is some evidence for humoral and cellular immune
selection focused on viral B- and T-cell epitopes [9,10]. DENV genetic diversity thus appears
to impact host mechanisms shown to mediate pathogenesis [11] and ultimately, disease
severity.
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Dengue was first identified in Papua New Guinea (PNG) when Sabin isolated the prototype
DENV-2New Guinea C strain from febrile soldiers deployed on the northern coast of New Guinea
in 1944 [12]. A DENV strain with similar biologic features as the prototype DENV-1Hawaii that
Sabin had recently isolated from febrile soldiers in Hawaii, was also isolated from soldiers in
the same area of New Guinea in 1944 [13], suggesting that at least two serotypes may have cir-
culated in the north of PNG in the 1940s. More recently, DENV-1-3 genetic data derived from
viremic travellers returning to northern Australia from PNG between 1999–2010 [14] indicate
that dengue is endemic in PNG, supporting an earlier serological study demonstrating a sero-
prevalence rate of 8% among patients presenting to clinics in Madang with acute febrile illness
[15]. Despite the likely transmission of multiple DENV serotypes and the potential for intro-
duction of DENV from endemic neighbouring countries which experience large-scale epidem-
ics of severe dengue [16], little is known about the epidemiology and transmission dynamics of
dengue in PNG, where dengue surveillance is not undertaken, individuals with acute febrile ill-
ness are not routinely tested for DENV infection, and where severe disease is rarely reported.
We sought to determine DENV serotype and genotype prevalence in local populations pre-
senting with febrile illness, or with a range of non-febrile conditions. We sequenced whole
genomes of DENV and conducted a phylogenetic analysis to determine the evolutionary origin
of PNG DENV. In addition we determined anti-DENV-1-4 neutralizing antibody profiles in
adults and children in order to assess prevalence and serotype diversity.
Materials and methods
Study area
Samples analysed in this study were collected from Madang, on the northern coast of PNG,
and from Lihir Island in New Ireland Province. Madang is a town of about 30,000 people with
a sea port that is a major hub for domestic and international shipping, and an airport where
domestic flights from throughout PNG arrive several times each day. Lihir Island is 800 kilo-
metres northeast of Madang in the Bismarck Archipelago, in the western Pacific Ocean. The
island’s population doubled to more than 12,000 people after establishment of a gold mine in
1997 and although many residents still live a predominantly traditional subsistence lifestyle, in
recent years there has been an influx of PNG-national and expatriate mine workers and devel-
opment of an international airport and sea port.
Patients and samples
Madang sera were collected from febrile patients presenting to the outpatient clinic of Yagaum
rural hospital or to Jomba town clinic from September 2007 through June 2008, and who were
enrolled in a malaria study [15]. Sera excluded for malaria antigens were tested for anti-DENV
IgG and IgM, and NS1 antigen; 8% (46/578) were identified as probable acute DENV infection
ie. NS1 antigen-positive and/or anti-DENV IgM-positive. A total of 55 acute phase sera (46
sera identified serologically as probable acute DENV infection plus 9 additional febrile sera
that were not tested for DENV), were assessed in the present study for the presence of DENV
by DENV E gene RT-PCR and virus isolation was attempted on RT-PCR positive samples.
Whole genomes of isolated viruses were sequenced using Illumina. Convalescent sera from
119 patients excluded for acute DENV infection and who presented for recollection were col-
lected an average of 29.6 days (range 5–159 days) after the first patient visit and tested for the
presence of anti-DENV neutralizing antibody (NAb) to all four serotypes simultaneously
using a microneutralization assay optimized for small sample volumes [17].
Lihir sera (55 in total) were collected from patients presenting to the outpatient clinic of
Lihir rural health centre from May through November 2010 during pre-employment medical
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visits, at antenatal screening visits, or from patients presenting for a range of conditions
including joint pain, diabetes and fever. The sera were also assessed for DENV genomes (11/55
sera from febrile patients) and for anti-DENV NAb (44/55 sea from patients with non-febrile
conditions).
Patient data are summarized in Table 1.
Ethical considerations
Ethics approval for this study was granted by the Medical Research Advisory Committee, Min-
istry of Health, Government of Papua New Guinea (2010) and the Human Research Ethics
Committee, University of Western Australia (2010). All data analysed were anonymized.
Virus isolation
DENV was isolated from serum by inoculation onto monolayers of Vero cells [5]. Briefly,
100μl of acute phase serum was inoculated onto a Vero cell monolayer in minimal media in a
2.5 ml culture tube, and incubated overnight. On the following day the inoculum was removed
and 3ml of DMEM with 2% FBS (supplemented with L-glutamine and antibiotics) was added
to the cells, and the culture was maintained at 37˚C with 5% CO2 for 7 days or until cytopathic
effect (CPE) was observed; for most samples a blind passage into a second 2.5 ml culture tube
was required in sorder to isolate virus. Successful virus isolation was identified by NS1 antigen
ELISA (Platelia Dengue NS1 Antigen ELISA; Bio-Rad, Australia).
RNA extraction and RT-PCR
Viral RNA was extracted from 140 μl of culture supernatant using QIAmp viral RNA Mini kits
(Qiagen), according to the manufacturer’s instructions. cDNA was synthesized from extracted
RNA using SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen) as per the
manufacturer’s instructions. DENV serotype was identified by RT-PCR using serotype-specific
primers [5], and the LongRange PCR Kit (Qiagen) (thermocycling conditions are available on
request).
Whole genome sequence analysis
RNA extraction and library preparation. DENV NS1-positive cultures were expanded
by passage in 25 ml tissue culture flasks in a volume of 15 ml. Supernatants were harvested and
clarified by centrifugation at 1400 rpm for 10 minutes at 4 deg C to remove cellular debris. The
clarified supernatant was then transferred to a Millipore centrifugal filter unit (100,000kDa)
and centrifuged at 4000 x g for 20 minutes. RNA was extracted from 150–200 μl concentrated
virus supernatant using the Roche High Pure RNA isolation kit as per the manufacturer’s
Table 1. Patient clinical and demographic data.




Acute DENV infection Madang September 2007 –June 2008 55 3 (0.5–50) 26 24 5
Lihir May-November 2010 11 39.5 (32–47) 1 1 9
Convalescent/non-infectious/non-febrile Madang October 2007 –July 2008 119 14.2 (0.5–60) 53 66
Lihir September-October 2010 44 25.5 (12–49) 5 39
 Not Specified
https://doi.org/10.1371/journal.pntd.0006254.t001
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instructions. RNA mass/concentration was then determined by fluorescent detection using the
Qubit system with Qubit RNA HS Assay kit (Invitrogen). All RNA was stored at -80˚C until
used. DNA libraries were prepared with the TruSeq Stranded mRNA kit (Illumina), with the
use of 200ng of total starting RNA and the exclusion of the polyA selection step. The DNA
library sizes were validated with a High Sensitivity DNA kit (Agilent) on the Agilent 2100
Bioanalyzer. The concentration of the libraries were normalised to 4nM using HT1 buffer sup-
plied by Illumina and pooled together. The final concentration of the pooled DNA library was
then re-examined using the Qubit ssDNA Assay kit (Invitrogen). The pooled DNA library was
sequenced using a MiSeq Reagent Nano Kit, v2 (Illumina).
Nucleic acid sequencing and phylogenetic analysis. Sequences were trimmed, quality
checked and assembled against DENV reference genomes into contigs using CLC Genomics
Workbench (Ver. 8.5.1). Complete assembled contigs were checked for chimeras and aligned
against publicly available sequences using MACSE [18]. Alignments were verified in Se-Al 2.0
(http://tree.bio.ed.ac.uk/software/seal/) and analyzed using RAxML to generate a maximum-
likelihood (ML) tree with ML bootstrap support based on the optimal number of ML bootstrap
replicates [19], using a general-time-reversible substitution model with among-site rate hetero-
geneity accounted for by the gamma model (GTR + gamma, best fit as indicated in
datamonkey.org). Trees were mid-point rooted. To identify nucleotide substitutions that have
occurred on the internal branches of lineages formed during the evolution of DENV, particu-
larly in PNG, we mapped changes onto the ML phylogenetic tree using a parsimony-based
method implemented in MacClade 4.08 [20].
Microneutralisation assay
A serum microneutralization (MN) assay was used to measure serum anti-DENV antibodies
[17]. This approach was selected to allow simultaneous assessment of antibody to all four
DENV serotypes in samples with limited volumes. Standard anti-DENV-1-4 sera NIBSC 05/
248 (National Institute for Biological Standards and Control [NIBSC], Potter’s Bar, Hertford-
shire, United Kingdom) were assayed against the homologous DENV prototype strains
DENV-1Hawaii2001; DENV-2NGC; DENV-3H-87 and DENV-4H-241 and consistently produced
MN titres of 10–20 and thus, the cut-off value for a positive test result was a reciprocal serum
dilution of 10. Subject results were summarized and presented as geometric mean titres
(GMT). Cross-neutralization experiments in which Standard DENV-1-4 sera were each tested
against heterologous prototype DENV consistently produced negative results. Standard anti-
JE serum (NIBSC 02/182) and serum samples from individuals with diagnosed other flavivirus
infection (JEV, MVEV, and KUNJV) were tested against DENV-1-4 and were always negative.
Accession numbers
All sequences have been deposited in GenBank and assigned accession numbers
KY794785-KY794790.
Results
Transmission of multiple DENV serotypes, PNG
Three circulating DENV serotypes: DENV-1, DENV-2 and DENV-3 were identified by full
length E gene PCR of acute phase serum samples from 17 febrile patients sampled in Madang
between 2007–2008 and Lihir in 2010 (Table 2).
DENV-1, DENV-2, and DENV-3 infections were identified in adults and children from
Madang town or from villages and rural settlements around the town. In several instances, two
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serotypes were identified in individuals sampled within a period of 10 days. Two DENV cases
originated in Lihir in May and October 2010 –a 47 year-old male Australian traveller infected
with DENV-2 and 32 year-old female resident of Lihir infected with DENV-3. These data
clearly identify hyperendemic DENV transmission on the northern coast of PNG, in Madang,
and on Lihir Island in the Bismarck Archipaleago.
Genome analysis identifies an endemic DENV-3 lineage that has evolved
locally
Whole genomes were sequenced from one DENV-2 and five DENV-3 isolates. Phylogenetic
analysis of the five DENV-3 isolates indicated that the four from Madang group together to
form a previously unidentified lineage within Genotype I (Fig 1). The Madang lineage
included other DENV-3 from the region, including a group exported to Solomon Islands and
Fiji and collected in 2013 [21] and 2014, respectively. The DENV-3 strain originating in Lihir
in 2010 also grouped within Genotype I and clustered with a lineage formed by DENV-3 first
found in travellers between PNG and northern Australia [14]. Collectively, these data identify
a lineage of DENV-3 endemic to the northern coast of PNG, closely related to DENV-3 circu-
lating in neighbouring Indonesia, and the subsequent introduction of this lineage into the
western and south Pacific. The entire lineage is well supported and distinguished from other
viruses within Genotype I by seven amino acid substitutions spanning several genes [prM, E,
NS2A, NS3, NS5] (Table 3) and are indicated by the highlighted branch in Figure I. Several of
these substitutions were non-conservative, involving the replacement of one encoded amino
acid with another of very different properties. At least two of these substitutions were fixed
through the process of positive selection according to at least one statistical test implemented
in HyPhy [22] and the online version Data Monkey (http://www.datamonkey.org/ [23, 24].
The Lihir 2010 DENV-2 virus grouped with the Cosmopolitan genotype (Fig 2) and clus-
tered with DENV-2 originating in Makassar, Indonesia in 2007 [25], and identified in travel-
lers between PNG and northern Australia [14]. Cosmopolitan DENV-2 circulates widely in
Table 2. DENV identified in febrile patients, PNG.
Sample Sex, Age (Years) Location Date collected DENV Serotype Strain ID GenBank Accession No.
1 M, 9 Madang 26-Sept-2007 1 - -
2 F, 21 Madang 05-Oct-2007 3 - -
3 F, 29 Madang 9-Oct-2007 3 D3_PNG_Madang_071009_2007 KY794787
4 F, 9 Madang 19-Dec-2007 2 - -
5 F, <1 Madang 4-Feb-2008 1 - -
6 NA, <1 Madang 6-Feb-2008 2 - -
7 F, 0.6 Madang 11-Feb-2008 2 - -
8 M, <1 Madang 24-Apr-2008 3 D3_PNG_Madang_080424_2008 KY794788
9 M, 3 Madang 25-April-2008 2 - -
10 F, 9 Madang 6-May-2008 2 - -
11 M, 0.5 Madang 14-May-2008 2 - -
12 F, 4 Madang 21-May-2008 3 D3_PNG_Madang_080521_2008 KY794789
13 M, <1 Madang 26-May-2008 2 - -
14 F, 1 Madang 6-June-2008 2 - -
15 M, 3 Madang 6-Jun-2008 3 D3_PNG_Madang_080606_2008 KY794790
16 M, 47 Lihir 11-May-2010 2 D2_PNG_Lihir_100511_2010 KY794785
17 F, 32 Lihir 27-Oct-2010 3 D3_PNG_Lihir_101027_2010 KY794786
https://doi.org/10.1371/journal.pntd.0006254.t002
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South and Southeast Asia, Africa, the Middle East, and northern Australia, and these data illus-
trate introduction of DENV-2 into the Western Pacific region from Southeast Asia.
Previous DENV infection
Overall dengue seroprevalence at the two study sites was 85.3%. Assessment of convalescent
sera from residents of Madang identified previous DENV infection in the great majority of
samples tested (101/119 sera; 84.9%), most of which showed multitypic NAb responses to all
four DENV serotypes (Table 4). DENV-2 and DENV-3 GMTs were of greatest magnitude.
Lihir sera showed a similar profile (Table 5) to that seen in Madang where the majority of sera
were seropositive (38/44; 86.4%), multitypic DENV-1-DENV-4 NAb responses predominated
and a majority neutralized all four serotypes. In both locations, monotypic NAb responses
were identified in 11% of sera and overall were directed against each of the four serotypes.
Seroprevalence increased with age (Table 6, Fig 3), a pattern that is typically seen in dengue-
endemic areas.
Discussion
Although dengue was first described in Papua New Guinea more than 70 years ago when
Sabin isolated the prototype DENV-2 strain New Guinea-C from US soldiers deployed along
the northern PNG coast during the Second World War [12], the lack of reported case data and
DENV transmission data since that time has meant that the distribution of dengue in PNG is
not understood. In this study we identified infection with three DENV serotypes among febrile
patients presenting to health clinics on the northern coast of PNG, in Madang, over a nine
month period in 2007–2008, and infection with two serotypes within 6 months in 2010, in
Lihir Island. These findings are consistent with hyperendemic DENV transmission between
2007–2010 and confirm that dengue is endemic in this country.
Fig 1. Phylogenetic tree of DENV-3 from Madang (2007–2008) and Lihir (2010). PNG DENV-3 (indicated in red)
compared with reference viruses obtained from GenBank. The PNG viruses grouped with genotype 1 of DENV-3.
Viruses isolated from Madang clustered together and were distinct from later strains, clustering with the Lihir isolate,
identified in travellers to northern Australia originating in PNG. The tree was derived by maximum likelihood
methods using whole genome sequences. Most reference virus sequences were complete envelope gene. Bootstrap
support values are shown at nodes.
https://doi.org/10.1371/journal.pntd.0006254.g001
Table 3. Substitutions along the DENV-3 PNG lineage formation.
Substitution Gene Region First Type Replacement Change
F242L membrane Phenylalanine; large (MW 165), nonpolar, aromatic Leucine; MW 131, nonpolar, aliphatic Nonconservative
L404S envelope Leucine; MW 131, nonpolar Serine; MW 105, polar, phosphorylated, O-glycosylated Nonconservative
V1305M1 NS2A Valine; MW 117, nonpolar Methionine; MW 149, nonpolar Nonconservative
T1592I NS3 Threonine; MW 119, polar, phosphorylated, O-
glycosylated
Isoleucine; MW 131, nonpolar Nonconservative
T1866S NS3 Threonine; MW 119, polar, phosphorylated, O-
glycosylated
Serine; MW 105, polar, phosphorylated, O-glycosylated Conservative
A2021S NS3 Alanine; MW 89, nonpolar Serine; MW 105, polar, phosphorylated, O-glycosylated Nonconservative
F3257Y2 NS5 Phenylalanine; large (MW 165), nonpolar, aromatic Tyrosine; MW 181, polar, phosphorylated, O-
glycosylated
Nonconservative
1 under positive selection according to the FEL, iFEL, and Toggle tests for selection
2 under positive selection according to the Toggle test for selection
https://doi.org/10.1371/journal.pntd.0006254.t003
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Our understanding of DENV transmission in PNG has previously been largely limited to
detection of DENV in febrile travellers to northern Australia [14]. The Madang DENV-3
Genotype 1 lineage evolved locally and circulated over the year the study was conducted. Our
phylogenetic analysis showed that it was most closely related to DENV-3 detected 3.5 years
later in the Solomon Islands in January 2103 and then in the Fiji Islands in 2014, likely
exported by travellers and having moved over distances of thousands of kilometres. PNG
shares geographic borders with Indonesia, where dengue epidemics occur regularly and
endemic, locally evolved DENV-3 lineages have been described [5, 25]. The Madang lineage is
most closely related to DENV-3 originating in Indonesia, as is the DENV-3 originating in
Lihir Island which clustered with DENV-3 identified in travellers to northern Australia.
Similarly, the DENV-2 virus identified in this study in a local resident of Lihir Island in 2010
is representative of strains known to circulate in the region, clustering with a highly similar strain
originating in Makassar, Indonesia, in 2007; both viruses belong to a DENV-2 (Cosmopolitan
genotype) clade also circulating in neighbouring Singapore in 2008 and identified in travellers to
northern Australia in 2004 and 2006. Our results provide further evidence of DENV movement
between endemic countries in the Asia Pacific region that has been described by ourselves and
others [26–29], and also illustrate the value of sequence data as a means of understanding virus
dispersal. PNG may be a source, or at least a place of transit, for dengue to enter the Pacific and
further disseminate to other Pacific Island nations.
Fig 2. Phylogenetic tree of DENV-2 from Lihir, October 2010. PNG DENV-2 (indicated in red) compared with
reference viruses obtained from GenBank. The Lihir virus grouped with the Cosmopolitan genotype of DENV-2, and
clustered with DENV-2 identified in travellers entering northern Australia from PNG 2009–2010. The tree was derived
by maximum likelihood methods using whole genome sequences. Most reference virus sequences were complete
envelope gene. Bootstrap support values are shown at nodes.
https://doi.org/10.1371/journal.pntd.0006254.g002
Table 4. Anti-DENV neutralizing antibody profiles, Madang.
Anti-DENV NAb-positive Anti-DENV NAb Titer
Serotype(s) No. positive (%) DENV-1 DENV-2 DENV-3 DENV-4
DENV-1 1 (1) 10 - - -
DENV-2 7 (6.9) - 14.9(10–40) - -
DENV-3 1 (1) - - 320 -
DENV-4 2 (2) - - - 10(10)
Sub-total, monotypic^ 11 (10.9)
DENV-1,-2 2 (2) 20 (20) 20 (20) - -
DENV-2,-3 6 (5.9) - 26.9 (10–80) 40 (10–320) -
DENV-2,-4 2 (2) - 20 (20) 20 (10–40) -
DENV-3,-4 2 (2) - - 20 (10–40) 10 (10)
DENV-1,-2,-3 2 (2) 113.1 (40–320) 20 (10–40) 28.3 (20–40) -
DENV-1,-2,-4 6 (5.9) 17.8 (10–40) 25.2 (10–80) - 15.9 (10–40)
DENV-1,-3,-4 5 (5) 13.2 (10–20) - 60.6 (10–320) 30.3 (20–40)
DENV-2,-3,-4 4 (4) - 14.1 (10–20) 20 (10–80) 14.1 (10–40)
DENV-1,-2,-3,-4 61 (60.4) 45.4 (10–640) 83.8 (10–640) 80.9 (10–640) 63.6 (10–640)
Sub-total, multiple 90 (89.1)
Total 101 (100)
Overall GMT 37.1(10–640) 61.5(10–640) 72.8(10–640) 46.4(10–640)
 NAb expressed as geometric mean titer (range)
^ Monotypic responses were largely in children (median age, 2 years)
- denotes titer <10
https://doi.org/10.1371/journal.pntd.0006254.t004
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DENV epidemic virulence has been linked to introduction and transmission of specific
serotypes and lineages [6,7]. The DENV-3 lineage we identified to be circulating in Madang in
2007–2008 and which our analysis showed to have evolved locally was subsequently associated
with hospitalizations and deaths when it was introduced into the Solomon Islands in 2013
[30], although severe disease was not identified among patients in Madang. This entire lineage
was distinguished by several amino acid substitutions that may influence virus phenotypic
Table 5. Anti-DENV neutralizing antibody profiles, Lihir.
Anti-DENV NAb-positive Anti-DENV NAb Titer 
Serotype(s) No. positive (%) DENV-1 DENV-2 DENV-3 DENV-4
DENV-1 2 (5.4) 10 - - -
DENV-2 1 (2.7) - 10 - -
DENV-3 1 (2.7) - - 10 -
DENV-4 0 (0) - - - -
Sub-total, monotypic 4 (10.5)
DENV-1,-2 2 (5.3) 20 20 (20–160) - -
DENV-1,-4 1 (2.7) 20 - - 10
DENV-2,-4 2 (5.3) - 20 (10–40) - 10
DENV-1,-2,-3 3 (7.9) 40 (10–160) 127 (80–320) 15.9 (10–20) -
DENV-2,-3,-4 4 (10.5) - 33.6 (10–80) 11.9 (10–20) 10
DENV-1,-2,-3,-4 22 (59.5) 25.7 (10–640) 49.9 (10–640) 30.1 (10–160) 22.7 (10–640)
Sub-total, multiple 34 (91.9)
Total 38 (100)
Overall GMT 26.3(10–640) 49.4(10–640) 24.8(10–160) 18.6 (10–160)
 NAb expressed as geometric mean titer (range)
- denotes titer <10
https://doi.org/10.1371/journal.pntd.0006254.t005
Table 6. Age and sex distribution for seropositive individuals.
Age (years) Frequency anti-DENV NAb-positive
Madang
Male, n = 53 Female, n = 66 Total, n = 119
No. sera No. positive (%) No. sera No. positive (%) No. sera No. positive (%)
<1 10 7 (70) 16 10 (62.5) 26 17 (65.4)
1–10 15 12 (80) 22 18 (81.8) 37 30 (81.1
11–20 9 8 (88.9) 12 11 (91.7) 21 19 (90.5)
21–30 10 10 (100) 7 7 (100) 17 17 (100)
31+ 8 8 (100) 9 9 (100) 17 17 (100)
NS 1 1 (100) 1 1 (100)
Total, Madang 53 46 (86.8) 66 55 (83.3) 119 101 (84.9)
Lihir Island
Male, n = 4 Female, n = 40 Total, n = 44
No. sera No. positive (%) No. sera No. positive (%) No. sera No. positive (%)
10–20 1 0(0) 2 2(100) 3 2 (66.7)
21–30 0 0 (0) 22 19 (86.4) 22 19 (86.4)
30+ 2 2 (100) 13 11 (84.6) 15 13 (86.7)
NS 1 1 (100) 3 3 (100) 4 4 (100)
Total, Lihir 4 2 (50) 40 35 (87.5) 44 38 (86.4)
https://doi.org/10.1371/journal.pntd.0006254.t006
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characteristics and ultimately, disease outcome. Severe dengue has also been linked to genetic
polymorphisms including HLA type [31]; PNG and the Solomon Islands both belong to the
Melanesian subgroup of Pacific Islanders and although relatively few HLA data are available
for this population group, certain allele frequencies are known to be shared. Studies to assess
the immunopathogenesis of dengue in PNG would be informative and should be undertaken
in future.
Dengue seroprevalence was very high with an overall rate of 85.3%, and increased with age.
More than half of seropositive individuals from Madang were greater than 11 years of age and
about 40% were older than 20 years. This age distribution reflects opportunities for multiple
exposures over the lifetime of the individual in a setting where dengue is endemic or is regu-
larly introduced and indeed, anti-DENV neutralising antibody profiles were predominantly
multitypic. A majority of individuals in Madang and in Lihir demonstrated responses to two
or more DENV serotypes and most sera neutralized all four DENV serotypes. Serum samples
included in this analysis were from two main groups–convalescent patients excluded for acute
DENV infection in Madang, and clinic attendees in Lihir (predominantly women attending
antenatal clinics) therefore these neutralization data likely reflect multiple DENV infections in
the years prior to sampling, and corroborate the genetic evidence for circulation of multiple
serotypes. Studies in rural Haiti and Nicaragua [32, 33] have shown that in endemic popula-
tions anti-DENV antibody prevalence increases with age and begins to plateau in adolescence
reflecting long-term exposure to, and infection with, endemically circulating DENV. In the
present study further support for endemic DENV transmission in PNG is indicated by the
young age (median 2 years) of individuals in Madang with monotypic anti-DENV NAb
responses to DENV-1, DENV-2, DENV-3 or DENV-4 whereas the majority of multitypic
infections were in adults. Three individuals with monotypic NAb profiles were babies less than
1 year old and anti-DENV NAb were likely passively transferred maternal antibody. We do
not know the age of the mothers but it is possible they were relatively young and/or had experi-
enced a single DENV infection in the past, or that they had experienced multiple infections
but that only antibodies to a single serotype were present at sufficiently high levels in the infant
to be detectable in our assay.
Hyperendemic DENV transmission is associated with symptomatic dengue infection
and with greater incidence of severe dengue [3]. No febrile patients were diagnosed with
Fig 3. Dengue seroprevalence in PNG. Columns represent age groups, and the proportion of NAb-positive sera is
shown for each group. Seroprevalence increases with age, plateauing after adults reach 20 years of age. Monotypic
infections (black line) decline to close to zero with increasing age.
https://doi.org/10.1371/journal.pntd.0006254.g003
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severe dengue in Madang [15] or Lihir and indeed, severe dengue is rarely identified in
PNG despite the hyperendemic transmission we have identified and which has likely been
occurring for a significant period of time. In previous studies we demonstrated high sero-
prevalence and predominantly multitypic NAb responses to all four serotypes in sera col-
lected in New Guinea between 1959–1963 [17] indicating DENV transmission in the
decades prior to sampling. The reasons for the rarity of severe disease are unclear but may
be related to poor recognition of dengue and the lack of routine dengue surveillance. It is
also possible that undefined DENV-specific immune mechanisms may contribute to the
apparent rarity of severe dengue disease.
In summary we have identified hyperendemic dengue transmission in PNG in the period
up to 2010, which has likely been occurring for many years. We also demonstrate circulation
of DENV which has evolved locally, and shown by others to have been introduced into the
western and south Pacific in subsequent years. The absence of regular sampling for DENV in
PNG and the potential for misdiagnosis of febrile individuals has meant that the evidence con-
sensus for dengue presence is low [2] and the true burden of disease is unknown. A dengue
outbreak in Port Moresby was confirmed by the PNG Department of Health in 2016 [34]
highlighting the need for additional studies to be undertaken to understand the epidemiology
and impact of dengue in this country. An important aspect of this is to understand the origin
and transmission patterns of PNG DENV, define endemic and introduced genotypes and line-
ages, and to characterize epidemic virulence associated with circulation of these viruses among
the PNG population and within the Asia Pacific region.
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